CMC Biologics Wins 2013 CMO Leadership Award for Innovation, Quality and Reliability

Source: PharmaManufacturing.com

Mar 20, 2013

PR Newswire

CMC Biologics, a global contract manufacturing organization known for its technical excellence in biopharmaceutical development and cGMP manufacture of protein based therapeutics, was recognized for innovation, quality and reliability by Life Science Leader at a prestigious ceremony at DCAT Week13 in New York last week.

"CMC Biologics is honored to receive this prestigious award and appreciate the recognition by Life Science Leader.  Our goal is to provide our customers with the highest standards of quality and reliability in both manufacturing and development, and which is the foundation of our customers' clinical and commercial success," said Claes Glassell, Chief Executive Officer. "The entire CMC Biologics' team is committed to continued improvement throughout our operations, and to continually innovate to advance biopharmaceutical manufacturing to the next level."

Bringing new pharmaceutical products to market is time consuming and costly, thereby having reliable and effective contract organizations to work with helps streamline that process. The Life Science Leader CMO Leadership awards are designed to honor top performers based on survey responses from thousands of industry executives, conducted by Nice Insight, and to better serve biopharmaceutical executives in their CMO selection process. These data will help companies focus on potential CMO partners who can handle their projects and are considered most reputable in the industry. For more information visit: www.cmoleadershipawards.com.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments